Article Versions Notes

Islam S, Teo T, Kumarasiri M, Slater M, Martin JH, Wang S, Head R. Combined In Silico and In Vitro Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells. Pharmaceuticals. 2022; 15(10):1186. https://doi.org/10.3390/ph15101186

Islam, Saiful, Theodosia Teo, Malika Kumarasiri, Martin Slater, Jennifer H. Martin, Shudong Wang, and Richard Head. 2022. "Combined In Silico and In Vitro Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells" Pharmaceuticals 15, no. 10: 1186. https://doi.org/10.3390/ph15101186

Islam, S., Teo, T., Kumarasiri, M., Slater, M., Martin, J. H., Wang, S., & Head, R. (2022). Combined In Silico and In Vitro Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells. Pharmaceuticals, 15(10), 1186. https://doi.org/10.3390/ph15101186